AAAshraf Saad Abou-Halawa

Ashraf Saad Abou-Halawa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ashraf Saad Abou-Halawa has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • A. A. Alrobaee

    Dermatology Department, College of Medicine, Qassim University, KSA

    1 shared publication
  • Amr Mohammed Fareed

    Otorhinolaryngology department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt

    1 shared publication
  • D.M. Elhennawi

    Department of Otorhinolaryngology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt

    1 shared publication
  • Diaa El-Din Mohamed El-Hennawi

    Otorhinolaryngology department Faculty of Medicine, Suez Canal University, Ismailia, Egypt

    1 shared publication
  • M. A. Khan

    Otorhinolaryngology Department, College of Medicine, Qassim University, KSA

    1 shared publication
  • Mohamed Rifaat Ahmed

    Faculty of Medicine, Suez Canal University, Ismailia, Egypt

    1 shared publication

Latest Publications

  • Open Access

    High Mobility Group A2 (HMGA2) and Matrix Metalloproteinase 12 (MMP12) Genes Expression in Egyptian Patients with Laryngeal Squamous Cell Carcinoma

    by Diaa El-Din Mohamed El-Hennawi, Mohamed Tawfik El Tabbakh, Nagwan Abd El-Aziz Sabek, Ashraf Saad Abou-Halawa, Amr Mohammed Fareed

    Background: genetic studies of laryngeal squamous cell carcinoma (LSCC) are rare in Egypt. Increased expression of some relevant genes may have diagnostic and therapeutic implications.Aim of the study: to compare the expression of HMGA2 and MMP12 genes in LSCC tumor tissue with their expression in adjacent non-tumor tissue.Type of the study: Descriptive studySetting: Tertiary referral hospital-Ismailia-EgyptPatients and Methods: 24 male patients (age range 49-78 years) with LSCC were included in the study. Under general anesthesia, two biopsies were taken: one from the tumor tissue and the other from the adjacent normal tissue and they were examined histopathologically and then analyzed for level of expression of MMP12 and HMGA2 genes.Results: Median expression levels of HMGA2 and MMP12 in the whole group were 0.98 and .8 (fold change) in normal tissue and 6.49 and 122.6 (fold change) in tumor tissue respectively. There was higher expression of the HMGA2 and MMP12 genes in tumor tissue compared to normal tissue (P <0.0001). Also there was positive correlation of level of expression of the two genes with the degree of tumor differentiation (P <.0001 and p<.0008)Conclusion: Expression of HMGA2 and MMP12 genes is higher in LSCC compared to normal tissue samples. The higher the level of expression of the two genes, the poorer the degree of differentiation of the tumor Further studies should be pursued to determine the diagnostic, therapeutic and prognostic implications of this in management of LSCC.


  • Correlation of obstructive sleep apnoea and laryngopharyngeal reflux: phmetry study

    by D.M. Elhennawi, Mohammed Rifaat Ahmed, Ashraf Saad Abou‐Halawa

    Objective: To study the correlation of obstructive sleep apnoea (OSA) and laryngopharyngeal reflux (LPR).Design: A descriptive study.Setting: Suez Canal University Hospital, Ismailia, Egypt.Patients: 62 patients with polysomnography confirmed OSA.Intervention: Patients were evaluated with ambulatory 24‐h double channel pH monitoring.Results: Mean reflux symptom index in the study group was 9 ± 5.5, and it was > 13 in all patients with severe OSA. Signs of LPR reflux were present in 34 (55%) patients. Abnormal reflux was detected in the distal oesophagus in 41 patients (66%) and in the proximal oesophagus in 21 patients (34%). Patients with severe OSA had significantly higher nocturnal LPR reflux episodes compared to patients with mild disease (P < .05). Number of reflux episodes and total duration of reflux during sleep are significantly correlated to degree of OSA (P < .05). No difference was found in relation to age or sex. Daytime reflux was not related to the degree of obstructive sleep apnoea (P > .05).Conclusion: LPR is common in patients with OSA. Patients with severe OSA have significantly higher nocturnal LPR. This should be considered when treating this group of patients.


  • Open Access

    Otomycosis with Perforated Tympanic Membrane : Self Medication with Topical Antifungal Solution versus Medicated Ear Wick

    by A. S. Abou-Halawa, M. A. Khan, A. A. Alrobaee

    In otomycosis with tympanic membrane perforation, many physicians prefer to insert an ear wick medicated with antimycotic cream. This needs multiple visits to the clinic and keeps the ear blocked for several days. Direct instillation of alcohol based antimycotic solution causes severe burning if it reaches the middle ear. In this work we compare patient's self medication with clotrimazole antimycotic solution used on Q-tips with physician-inserted ear wicks; in terms of safety, efficacy and patient satisfaction. STUDY DESIGN #ENTITYSTARTX00026; Prospective controlled study in ambulatory setting. Forty consecutive patients with otomycosis with tympanic membrane perforation were included in the study. Diagnosis of otomycosis was both clinical and with mycological culture. Mean pure tone average (PTA) in the involved ear was measured after cleaning fungal debris. Patients were then, randomized into two groups; Q-tip group patients (n=20) were taught to self-medicate their ears two times daily with the clotrimazole solution on suitable Q-tips for three weeks. In ear wick group (n=20), a gauze wick impregnated with clotrimazole cream was inserted in the ear. Wick was changed every third day for two more visits (one week overall). Patients were followed up for 3 months. After three weeks all patients in Q-tip group and ear wick group had relief of their ear itching and complete disappearance of fungal growth in the deep meatus and on the tympanic membrane. PTA was 22 ± 11dB in Q-tip group and 25 ± 12 dB in ear wick group; the difference was not statistically significant (p= 0.11). Patients in ear wick group had sense of ear blocking and wetness during period of treatment. Transient burning sensation was reported by 2 patients in Q-tip group. During three months, there was recurrence of otomycosis in 5 patients from ear wick group and no recurrence in Q-tip group (p=0.04). Self medication with clotrimazole solution on Q-tips and physician inserted medicated wicks are equally safe in treating otomycosis with perforated tympanic membrane. However, self medication with antimycotic solution on Q-tips gives more patient satisfaction and less rate of otomycosis recurrence.